| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | frizzled binding | 3.32e-04 | 42 | 13 | 2 | GO:0005109 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 4.76e-03 | 547 | 13 | 3 | GO:0048018 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 4.94e-03 | 554 | 13 | 3 | GO:0030546 | |
| GeneOntologyMolecularFunction | integrin binding | 5.59e-03 | 175 | 13 | 2 | GO:0005178 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 6.14e-03 | 599 | 13 | 3 | GO:0050839 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 6.42e-03 | 188 | 13 | 2 | GO:0005201 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 6.63e-03 | 616 | 13 | 3 | GO:0030545 | |
| GeneOntologyMolecularFunction | cytokine activity | 1.11e-02 | 250 | 13 | 2 | GO:0005125 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 1.96e-02 | 337 | 13 | 2 | GO:0001664 | |
| GeneOntologyBiologicalProcess | mesenchymal-epithelial cell signaling | 4.29e-08 | 12 | 13 | 3 | GO:0060638 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 3.20e-05 | 1125 | 13 | 6 | GO:0035239 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial bud | 5.58e-05 | 18 | 13 | 2 | GO:0060572 | |
| GeneOntologyBiologicalProcess | kidney development | 6.54e-05 | 372 | 13 | 4 | GO:0001822 | |
| GeneOntologyBiologicalProcess | renal system development | 7.55e-05 | 386 | 13 | 4 | GO:0072001 | |
| GeneOntologyBiologicalProcess | branch elongation of an epithelium | 8.41e-05 | 22 | 13 | 2 | GO:0060602 | |
| GeneOntologyBiologicalProcess | tube development | 1.10e-04 | 1402 | 13 | 6 | GO:0035295 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial fold | 1.47e-04 | 29 | 13 | 2 | GO:0060571 | |
| GeneOntologyBiologicalProcess | regulation of animal organ formation | 1.80e-04 | 32 | 13 | 2 | GO:0003156 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage cytokine production | 1.91e-04 | 33 | 13 | 2 | GO:0060907 | |
| GeneOntologyBiologicalProcess | prostate gland epithelium morphogenesis | 1.91e-04 | 33 | 13 | 2 | GO:0060740 | |
| GeneOntologyBiologicalProcess | prostate gland morphogenesis | 2.03e-04 | 34 | 13 | 2 | GO:0060512 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 2.32e-04 | 198 | 13 | 3 | GO:0048754 | |
| GeneOntologyBiologicalProcess | axis elongation | 2.55e-04 | 38 | 13 | 2 | GO:0003401 | |
| GeneOntologyBiologicalProcess | specification of animal organ identity | 2.97e-04 | 41 | 13 | 2 | GO:0010092 | |
| GeneOntologyBiologicalProcess | epithelial tube branching involved in lung morphogenesis | 2.97e-04 | 41 | 13 | 2 | GO:0060441 | |
| GeneOntologyBiologicalProcess | glandular epithelial cell development | 3.26e-04 | 43 | 13 | 2 | GO:0002068 | |
| GeneOntologyBiologicalProcess | hematopoietic stem cell proliferation | 3.26e-04 | 43 | 13 | 2 | GO:0071425 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid leukocyte cytokine production involved in immune response | 3.74e-04 | 46 | 13 | 2 | GO:0061081 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 3.89e-04 | 236 | 13 | 3 | GO:0061138 | |
| GeneOntologyBiologicalProcess | regulation of macrophage cytokine production | 4.07e-04 | 48 | 13 | 2 | GO:0010935 | |
| GeneOntologyBiologicalProcess | negative chemotaxis | 4.59e-04 | 51 | 13 | 2 | GO:0050919 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 5.04e-04 | 258 | 13 | 3 | GO:0001763 | |
| GeneOntologyBiologicalProcess | axon development | 5.31e-04 | 642 | 13 | 4 | GO:0061564 | |
| GeneOntologyBiologicalProcess | macrophage cytokine production | 5.34e-04 | 55 | 13 | 2 | GO:0010934 | |
| GeneOntologyBiologicalProcess | olfactory lobe development | 5.54e-04 | 56 | 13 | 2 | GO:0021988 | |
| GeneOntologyBiologicalProcess | lung development | 5.69e-04 | 269 | 13 | 3 | GO:0030324 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 5.94e-04 | 273 | 13 | 3 | GO:0030323 | |
| GeneOntologyBiologicalProcess | axon guidance | 6.74e-04 | 285 | 13 | 3 | GO:0007411 | |
| GeneOntologyBiologicalProcess | prostate gland development | 6.79e-04 | 62 | 13 | 2 | GO:0030850 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 6.81e-04 | 286 | 13 | 3 | GO:0097485 | |
| GeneOntologyBiologicalProcess | regulation of morphogenesis of a branching structure | 7.46e-04 | 65 | 13 | 2 | GO:0060688 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 7.74e-04 | 299 | 13 | 3 | GO:0060560 | |
| GeneOntologyBiologicalProcess | respiratory system development | 8.20e-04 | 305 | 13 | 3 | GO:0060541 | |
| GeneOntologyBiologicalProcess | columnar/cuboidal epithelial cell development | 8.40e-04 | 69 | 13 | 2 | GO:0002066 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte cytokine production | 9.14e-04 | 72 | 13 | 2 | GO:0061082 | |
| GeneOntologyBiologicalProcess | cellular response to retinoic acid | 9.40e-04 | 73 | 13 | 2 | GO:0071300 | |
| GeneOntologyBiologicalProcess | regulation of morphogenesis of an epithelium | 1.02e-03 | 76 | 13 | 2 | GO:1905330 | |
| GeneOntologyBiologicalProcess | lung morphogenesis | 1.04e-03 | 77 | 13 | 2 | GO:0060425 | |
| GeneOntologyBiologicalProcess | animal organ formation | 1.07e-03 | 78 | 13 | 2 | GO:0048645 | |
| GeneOntologyBiologicalProcess | urogenital system development | 1.10e-03 | 79 | 13 | 2 | GO:0001655 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.10e-03 | 338 | 13 | 3 | GO:0045165 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 1.31e-03 | 817 | 13 | 4 | GO:0048514 | |
| GeneOntologyBiologicalProcess | epithelium development | 1.44e-03 | 1469 | 13 | 5 | GO:0060429 | |
| GeneOntologyBiologicalProcess | glandular epithelial cell differentiation | 1.45e-03 | 91 | 13 | 2 | GO:0002067 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 1.51e-03 | 1483 | 13 | 5 | GO:0048646 | |
| GeneOntologyBiologicalProcess | positive regulation of cytokine production involved in immune response | 1.72e-03 | 99 | 13 | 2 | GO:0002720 | |
| GeneOntologyBiologicalProcess | lens development in camera-type eye | 1.86e-03 | 103 | 13 | 2 | GO:0002088 | |
| GeneOntologyBiologicalProcess | regulation of axon extension | 1.89e-03 | 104 | 13 | 2 | GO:0030516 | |
| GeneOntologyBiologicalProcess | developmental growth | 1.96e-03 | 911 | 13 | 4 | GO:0048589 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 2.07e-03 | 421 | 13 | 3 | GO:0060562 | |
| GeneOntologyBiologicalProcess | blood vessel development | 2.11e-03 | 929 | 13 | 4 | GO:0001568 | |
| GeneOntologyBiologicalProcess | regulation of animal organ morphogenesis | 2.12e-03 | 110 | 13 | 2 | GO:2000027 | |
| GeneOntologyBiologicalProcess | negative regulation of cell population proliferation | 2.39e-03 | 961 | 13 | 4 | GO:0008285 | |
| GeneOntologyBiologicalProcess | vasculature development | 2.46e-03 | 969 | 13 | 4 | GO:0001944 | |
| GeneOntologyBiologicalProcess | body fluid secretion | 2.55e-03 | 121 | 13 | 2 | GO:0007589 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 2.59e-03 | 122 | 13 | 2 | GO:0061387 | |
| GeneOntologyBiologicalProcess | response to retinoic acid | 2.98e-03 | 131 | 13 | 2 | GO:0032526 | |
| GeneOntologyBiologicalProcess | response to fibroblast growth factor | 3.03e-03 | 132 | 13 | 2 | GO:0071774 | |
| GeneOntologyCellularComponent | extracellular matrix | 7.34e-07 | 656 | 12 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 7.47e-07 | 658 | 12 | 6 | GO:0030312 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 7.03e-06 | 530 | 12 | 5 | GO:0062023 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.72e-03 | 109 | 12 | 2 | GO:0005796 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 6.32e-03 | 212 | 12 | 2 | GO:0030666 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.49e-02 | 332 | 12 | 2 | GO:0005788 | |
| Domain | EGF | 1.35e-06 | 126 | 13 | 4 | PF00008 | |
| Domain | EGF_extracell | 8.81e-06 | 60 | 13 | 3 | IPR013111 | |
| Domain | EGF_2 | 8.81e-06 | 60 | 13 | 3 | PF07974 | |
| Domain | EGF_3 | 1.60e-05 | 235 | 13 | 4 | PS50026 | |
| Domain | EGF | 1.60e-05 | 235 | 13 | 4 | SM00181 | |
| Domain | EGF-like_dom | 2.01e-05 | 249 | 13 | 4 | IPR000742 | |
| Domain | EGF_1 | 2.20e-05 | 255 | 13 | 4 | PS00022 | |
| Domain | EGF-like_CS | 2.41e-05 | 261 | 13 | 4 | IPR013032 | |
| Domain | EGF_2 | 2.56e-05 | 265 | 13 | 4 | PS01186 | |
| Domain | TIL | 2.94e-05 | 12 | 13 | 2 | PF01826 | |
| Domain | C8 | 2.94e-05 | 12 | 13 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 3.47e-05 | 13 | 13 | 2 | IPR014853 | |
| Domain | C8 | 3.47e-05 | 13 | 13 | 2 | SM00832 | |
| Domain | TIL_dom | 4.05e-05 | 14 | 13 | 2 | IPR002919 | |
| Domain | VWFD | 5.34e-05 | 16 | 13 | 2 | PS51233 | |
| Domain | VWD | 5.34e-05 | 16 | 13 | 2 | SM00216 | |
| Domain | VWF_type-D | 5.34e-05 | 16 | 13 | 2 | IPR001846 | |
| Domain | VWD | 5.34e-05 | 16 | 13 | 2 | PF00094 | |
| Domain | Wnt | 7.60e-05 | 19 | 13 | 2 | IPR005817 | |
| Domain | VWC_out | 7.60e-05 | 19 | 13 | 2 | SM00215 | |
| Domain | WNT1 | 7.60e-05 | 19 | 13 | 2 | SM00097 | |
| Domain | Wnt_CS | 7.60e-05 | 19 | 13 | 2 | IPR018161 | |
| Domain | wnt | 7.60e-05 | 19 | 13 | 2 | PF00110 | |
| Domain | WNT1 | 7.60e-05 | 19 | 13 | 2 | PS00246 | |
| Domain | Growth_fac_rcpt_ | 1.54e-04 | 156 | 13 | 3 | IPR009030 | |
| Domain | VWFC_1 | 2.78e-04 | 36 | 13 | 2 | PS01208 | |
| Domain | VWC | 3.10e-04 | 38 | 13 | 2 | SM00214 | |
| Domain | VWFC_2 | 3.10e-04 | 38 | 13 | 2 | PS50184 | |
| Domain | VWF_dom | 3.79e-04 | 42 | 13 | 2 | IPR001007 | |
| Domain | EGF_CA | 3.15e-03 | 122 | 13 | 2 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.25e-03 | 124 | 13 | 2 | IPR001881 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 4.63e-05 | 118 | 9 | 3 | M39852 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 6.16e-05 | 19 | 9 | 2 | M47836 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.02e-04 | 154 | 9 | 3 | M39739 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 1.08e-04 | 25 | 9 | 2 | MM14940 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.17e-04 | 161 | 9 | 3 | M39770 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 1.17e-04 | 26 | 9 | 2 | M27239 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 1.36e-04 | 28 | 9 | 2 | M47835 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.46e-04 | 29 | 9 | 2 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.46e-04 | 29 | 9 | 2 | M47377 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 2.26e-04 | 36 | 9 | 2 | M39699 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 2.39e-04 | 37 | 9 | 2 | M47411 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 3.38e-04 | 44 | 9 | 2 | MM15878 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 3.54e-04 | 45 | 9 | 2 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 3.70e-04 | 46 | 9 | 2 | M47409 | |
| Pathway | WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY | 4.03e-04 | 48 | 9 | 2 | M39427 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 5.29e-04 | 55 | 9 | 2 | M17807 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 5.48e-04 | 56 | 9 | 2 | M1053 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 6.08e-04 | 59 | 9 | 2 | M46460 | |
| Pathway | WP_WNT_SIGNALING | 6.50e-04 | 61 | 9 | 2 | MM15893 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 8.08e-04 | 68 | 9 | 2 | M27303 | |
| Pathway | WP_AXON_GUIDANCE | 9.05e-04 | 72 | 9 | 2 | M48335 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 1.26e-03 | 85 | 9 | 2 | M48315 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 1.38e-03 | 89 | 9 | 2 | M39563 | |
| Pathway | WNT_SIGNALING | 1.38e-03 | 89 | 9 | 2 | M5493 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 1.54e-03 | 94 | 9 | 2 | M797 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 1.67e-03 | 98 | 9 | 2 | M39731 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 1.77e-03 | 101 | 9 | 2 | MM15829 | |
| Pathway | KEGG_MELANOGENESIS | 1.77e-03 | 101 | 9 | 2 | M7761 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 1.77e-03 | 101 | 9 | 2 | M39387 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.06e-03 | 109 | 9 | 2 | MM15164 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 2.10e-03 | 110 | 9 | 2 | M39492 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 2.21e-03 | 113 | 9 | 2 | M39669 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 2.33e-03 | 116 | 9 | 2 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 2.37e-03 | 117 | 9 | 2 | M39530 | |
| Pathway | WP_CANCER_PATHWAYS | 3.30e-03 | 507 | 9 | 3 | M48302 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 3.51e-03 | 143 | 9 | 2 | M27275 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 3.91e-03 | 151 | 9 | 2 | M19428 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 9.53e-03 | 239 | 9 | 2 | MM14756 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.04e-02 | 250 | 9 | 2 | M27554 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.13e-02 | 261 | 9 | 2 | M42565 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.71e-02 | 325 | 9 | 2 | M12868 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 1.72e-02 | 326 | 9 | 2 | M39379 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.76e-02 | 330 | 9 | 2 | M7847 | |
| Pubmed | Wnt2b and Wnt5a expression is highly associated with M2 TAMs in non‑small cell lung cancer. | 1.29e-07 | 2 | 13 | 2 | 36102318 | |
| Pubmed | Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer. | 1.29e-07 | 2 | 13 | 2 | 29999571 | |
| Pubmed | Role of members of the Wnt gene family in human hematopoiesis. | 3.87e-07 | 3 | 13 | 2 | 9787155 | |
| Pubmed | 5.36e-07 | 44 | 13 | 3 | 23884445 | ||
| Pubmed | 7.74e-07 | 4 | 13 | 2 | 22691042 | ||
| Pubmed | 1.93e-06 | 6 | 13 | 2 | 23250740 | ||
| Pubmed | 2.71e-06 | 7 | 13 | 2 | 11767049 | ||
| Pubmed | Wnt5a controls neurite development in olfactory bulb interneurons. | 3.61e-06 | 8 | 13 | 2 | 21539518 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 4.10e-06 | 86 | 13 | 3 | 28327460 | |
| Pubmed | Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. | 4.64e-06 | 9 | 13 | 2 | 11092808 | |
| Pubmed | 4.64e-06 | 9 | 13 | 2 | 22691363 | ||
| Pubmed | Expression patterns of Wnt genes during development of an anterior part of the chicken eye. | 5.79e-06 | 10 | 13 | 2 | 16258938 | |
| Pubmed | Patterning of the dorsal telencephalon and cerebral cortex by a roof plate-Lhx2 pathway. | 8.49e-06 | 12 | 13 | 2 | 11719201 | |
| Pubmed | Emx2 is required for growth of the hippocampus but not for hippocampal field specification. | 1.00e-05 | 13 | 13 | 2 | 10729342 | |
| Pubmed | 1.00e-05 | 13 | 13 | 2 | 17848411 | ||
| Pubmed | 1.17e-05 | 14 | 13 | 2 | 9584130 | ||
| Pubmed | 1.35e-05 | 15 | 13 | 2 | 15044261 | ||
| Pubmed | 1.35e-05 | 15 | 13 | 2 | 38537630 | ||
| Pubmed | 1.35e-05 | 15 | 13 | 2 | 26883626 | ||
| Pubmed | LDB1 Is Required for the Early Development of the Dorsal Telencephalon and the Thalamus. | 1.54e-05 | 16 | 13 | 2 | 30873428 | |
| Pubmed | 1.54e-05 | 16 | 13 | 2 | 10585256 | ||
| Pubmed | 1.54e-05 | 16 | 13 | 2 | 22677559 | ||
| Pubmed | 1.54e-05 | 16 | 13 | 2 | 19890917 | ||
| Pubmed | Specific glial populations regulate hippocampal morphogenesis. | 1.54e-05 | 16 | 13 | 2 | 19020026 | |
| Pubmed | 1.54e-05 | 16 | 13 | 2 | 9889131 | ||
| Pubmed | Wnt family proteins are secreted and associated with the cell surface. | 1.75e-05 | 17 | 13 | 2 | 8167409 | |
| Pubmed | Mesenchymal Wnt signaling promotes formation of sternum and thoracic body wall. | 1.75e-05 | 17 | 13 | 2 | 25727890 | |
| Pubmed | 1.97e-05 | 18 | 13 | 2 | 26321050 | ||
| Pubmed | 1.97e-05 | 18 | 13 | 2 | 22166339 | ||
| Pubmed | 1.97e-05 | 18 | 13 | 2 | 14628042 | ||
| Pubmed | DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice. | 1.97e-05 | 145 | 13 | 3 | 21308776 | |
| Pubmed | LIM-homeodomain gene Lhx2 regulates the formation of the cortical hem. | 2.20e-05 | 19 | 13 | 2 | 11165475 | |
| Pubmed | A Wnt/Notch/Pax7 signaling network supports tissue integrity in tongue development. | 2.20e-05 | 19 | 13 | 2 | 28438836 | |
| Pubmed | 2.20e-05 | 19 | 13 | 2 | 11520664 | ||
| Pubmed | Coronary Artery Formation Is Driven by Localized Expression of R-spondin3. | 2.20e-05 | 19 | 13 | 2 | 28834739 | |
| Pubmed | 2.31e-05 | 153 | 13 | 3 | 25037231 | ||
| Pubmed | The transcription factor Maz is essential for normal eye development. | 2.70e-05 | 21 | 13 | 2 | 32571845 | |
| Pubmed | 2.70e-05 | 21 | 13 | 2 | 19806668 | ||
| Pubmed | Epithelial Wnt10a Is Essential for Tooth Root Furcation Morphogenesis. | 2.70e-05 | 21 | 13 | 2 | 31914354 | |
| Pubmed | The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium. | 2.70e-05 | 21 | 13 | 2 | 11914369 | |
| Pubmed | 2.97e-05 | 22 | 13 | 2 | 12815618 | ||
| Pubmed | 3.25e-05 | 23 | 13 | 2 | 27362799 | ||
| Pubmed | Endodermal Wnt signaling is required for tracheal cartilage formation. | 3.25e-05 | 23 | 13 | 2 | 26093309 | |
| Pubmed | 3.54e-05 | 24 | 13 | 2 | 19165927 | ||
| Pubmed | 3.54e-05 | 24 | 13 | 2 | 28729440 | ||
| Pubmed | 3.85e-05 | 25 | 13 | 2 | 15136151 | ||
| Pubmed | 3.85e-05 | 25 | 13 | 2 | 17468181 | ||
| Pubmed | 3.85e-05 | 25 | 13 | 2 | 20185815 | ||
| Pubmed | 4.50e-05 | 27 | 13 | 2 | 17804636 | ||
| Pubmed | 4.85e-05 | 28 | 13 | 2 | 20940229 | ||
| Pubmed | Ectodermal Wnt signaling regulates abdominal myogenesis during ventral body wall development. | 4.85e-05 | 28 | 13 | 2 | 24394376 | |
| Pubmed | 4.85e-05 | 28 | 13 | 2 | 21896628 | ||
| Pubmed | Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. | 5.21e-05 | 29 | 13 | 2 | 22956684 | |
| Pubmed | 5.21e-05 | 29 | 13 | 2 | 18364260 | ||
| Pubmed | Atlas of Wnt and R-spondin gene expression in the developing male mouse lower urogenital tract. | 5.58e-05 | 30 | 13 | 2 | 21936019 | |
| Pubmed | 5.58e-05 | 30 | 13 | 2 | 15880404 | ||
| Pubmed | 5.58e-05 | 30 | 13 | 2 | 19282366 | ||
| Pubmed | Overactive Wnt5a signaling disrupts hair follicle polarity during mouse skin development. | 5.58e-05 | 30 | 13 | 2 | 36305473 | |
| Pubmed | 5.96e-05 | 31 | 13 | 2 | 22711842 | ||
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 5.96e-05 | 31 | 13 | 2 | 31550482 | |
| Pubmed | 7.62e-05 | 35 | 13 | 2 | 31167144 | ||
| Pubmed | 7.62e-05 | 35 | 13 | 2 | 30940800 | ||
| Pubmed | 7.62e-05 | 35 | 13 | 2 | 23376422 | ||
| Pubmed | 7.62e-05 | 35 | 13 | 2 | 19185060 | ||
| Pubmed | Dual regulation of planar polarization by secreted Wnts and Vangl2 in the developing mouse cochlea. | 7.62e-05 | 35 | 13 | 2 | 32907846 | |
| Pubmed | 8.07e-05 | 36 | 13 | 2 | 12412008 | ||
| Pubmed | 8.07e-05 | 36 | 13 | 2 | 15800025 | ||
| Pubmed | 8.07e-05 | 36 | 13 | 2 | 24151333 | ||
| Pubmed | 8.07e-05 | 36 | 13 | 2 | 31604927 | ||
| Pubmed | Integrated analysis of Wnt signalling system component gene expression. | 8.53e-05 | 37 | 13 | 2 | 35831952 | |
| Pubmed | 8.53e-05 | 37 | 13 | 2 | 15342465 | ||
| Pubmed | Tissue-specific requirements of beta-catenin in external genitalia development. | 9.00e-05 | 38 | 13 | 2 | 18635608 | |
| Pubmed | 9.00e-05 | 38 | 13 | 2 | 23190887 | ||
| Pubmed | Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals. | 9.00e-05 | 38 | 13 | 2 | 21041481 | |
| Pubmed | 9.48e-05 | 39 | 13 | 2 | 24586192 | ||
| Pubmed | 9.98e-05 | 40 | 13 | 2 | 16210410 | ||
| Pubmed | 1.05e-04 | 41 | 13 | 2 | 22675208 | ||
| Pubmed | Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. | 1.38e-04 | 47 | 13 | 2 | 16678101 | |
| Pubmed | Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis. | 1.38e-04 | 47 | 13 | 2 | 28813421 | |
| Pubmed | 1.38e-04 | 47 | 13 | 2 | 33141892 | ||
| Pubmed | 1.38e-04 | 47 | 13 | 2 | 18351675 | ||
| Pubmed | Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. | 1.50e-04 | 49 | 13 | 2 | 19562671 | |
| Pubmed | WNT signaling affects gene expression in the ventral diencephalon and pituitary gland growth. | 1.56e-04 | 50 | 13 | 2 | 18351662 | |
| Pubmed | Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior. | 1.96e-04 | 56 | 13 | 2 | 29184203 | |
| Pubmed | Mesenchymal Hox6 function is required for mouse pancreatic endocrine cell differentiation. | 2.18e-04 | 59 | 13 | 2 | 26450967 | |
| Pubmed | A cellular and spatial map of the choroid plexus across brain ventricles and ages. | 2.18e-04 | 59 | 13 | 2 | 33932339 | |
| Pubmed | 2.49e-04 | 63 | 13 | 2 | 22923088 | ||
| Pubmed | 2.98e-04 | 69 | 13 | 2 | 30352686 | ||
| GeneFamily | Wnt family|Endogenous ligands | 3.75e-05 | 19 | 9 | 2 | 360 | |
| Coexpression | HEVNER_CORTEX_CORTICAL_HEM | 1.74e-05 | 14 | 12 | 2 | MM443 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 2.84e-05 | 135 | 12 | 3 | M5825 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 4.98e-05 | 163 | 12 | 3 | M12112 | |
| Coexpression | NABA_MATRISOME | 5.26e-05 | 1008 | 12 | 5 | MM17056 | |
| Coexpression | NABA_MATRISOME | 5.73e-05 | 1026 | 12 | 5 | M5889 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 9.46e-05 | 32 | 12 | 2 | M5903 | |
| Coexpression | LIU_CDX2_TARGETS_UP | 1.13e-04 | 35 | 12 | 2 | M16637 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 1.44e-04 | 233 | 12 | 3 | M7094 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 2.15e-04 | 267 | 12 | 3 | MM1091 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 2.58e-04 | 738 | 12 | 4 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 2.75e-04 | 751 | 12 | 4 | M5885 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 2.99e-04 | 767 | 12 | 4 | M39209 | |
| Coexpression | TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL | 3.93e-04 | 65 | 12 | 2 | M41673 | |
| Coexpression | GU_PDEF_TARGETS_UP | 4.69e-04 | 71 | 12 | 2 | M3955 | |
| Coexpression | DARWICHE_PAPILLOMA_PROGRESSION_RISK | 5.52e-04 | 77 | 12 | 2 | M1147 | |
| Coexpression | YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP | 6.41e-04 | 83 | 12 | 2 | M10660 | |
| Coexpression | HINATA_NFKB_TARGETS_KERATINOCYTE_UP | 6.56e-04 | 84 | 12 | 2 | M11951 | |
| Coexpression | KANG_IMMORTALIZED_BY_TERT_UP | 7.20e-04 | 88 | 12 | 2 | M5360 | |
| Coexpression | DESCARTES_MAIN_FETAL_INTESTINAL_EPITHELIAL_CELLS | 7.52e-04 | 90 | 12 | 2 | M40112 | |
| Coexpression | YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP | 7.69e-04 | 91 | 12 | 2 | MM622 | |
| Coexpression | DARWICHE_PAPILLOMA_PROGRESSION_RISK | 7.86e-04 | 92 | 12 | 2 | MM503 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | 8.18e-04 | 422 | 12 | 3 | M7396 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 2.06e-06 | 466 | 11 | 5 | GSM777050_500 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_500 | 4.34e-05 | 417 | 11 | 4 | gudmap_kidney_adult_RenMedVasc_Tie2_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 5.21e-05 | 437 | 11 | 4 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 5.30e-05 | 439 | 11 | 4 | GSM777059_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 5.84e-05 | 450 | 11 | 4 | GSM777063_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.21e-04 | 196 | 11 | 3 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#1 | 2.95e-04 | 50 | 11 | 2 | ratio_EB_vs_SC_500_K1 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.71e-04 | 311 | 11 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.45e-04 | 327 | 11 | 3 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K2 | 5.74e-04 | 333 | 11 | 3 | gudmap_RNAseq_e15.5_Podocytes_2500_K2 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.95e-04 | 337 | 11 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000 | 6.71e-04 | 850 | 11 | 4 | gudmap_kidney_adult_RenMedVasc_Tie2_1000 | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_top-relative-expression-ranked_1000 | 6.77e-04 | 852 | 11 | 4 | gudmap_kidney_adult_GlomCapSys_Tie2_1000 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | 7.39e-04 | 872 | 11 | 4 | gudmap_kidney_adult_Mesangium_Meis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_500 | 7.92e-04 | 82 | 11 | 2 | gudmap_developingGonad_e12.5_testes_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | 7.93e-04 | 372 | 11 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 | |
| ToppCell | CV-Mild-4|CV / Virus stimulation, Condition and Cluster | 9.48e-06 | 160 | 12 | 3 | be89efeeecb0de96ce136a7a62738f15dc0badb2 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.00e-05 | 163 | 12 | 3 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | AT1-AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.16e-05 | 171 | 12 | 3 | 0b9912f07393aca889db72b40da08e0bc9bc1e8c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-05 | 174 | 12 | 3 | cc4c7f00a25a7814b52d4599166615daa140cc31 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 181 | 12 | 3 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 187 | 12 | 3 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 187 | 12 | 3 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 187 | 12 | 3 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 187 | 12 | 3 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 187 | 12 | 3 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 188 | 12 | 3 | da862ea3c74f42d0dbae38b09211a45c593d477e | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 188 | 12 | 3 | b82a7667ef74a05e8bc744f6c090a7cc7b8efe32 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 188 | 12 | 3 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 188 | 12 | 3 | 19672d284fe89c9c3c7697514ca1f659329c34f4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 189 | 12 | 3 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 191 | 12 | 3 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 192 | 12 | 3 | 0986b7900021efe2a4df84a935e7c9a0af1b0e57 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 192 | 12 | 3 | 8f20d3511dcb44445592b17d005a53da0052ae56 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 192 | 12 | 3 | b28d294e42b303d1db6060231d84d7b9e4d9fccf | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.64e-05 | 192 | 12 | 3 | dc4b4e16e6eb212e45fb70695afd1c7e91027407 | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.66e-05 | 193 | 12 | 3 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 194 | 12 | 3 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-05 | 195 | 12 | 3 | 2eed0332e338d6f0dbcb399d9d36c4611d491b0a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.71e-05 | 195 | 12 | 3 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-05 | 196 | 12 | 3 | acbb493dbb49a33f20cf11106363f7ed51209706 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-05 | 197 | 12 | 3 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-05 | 197 | 12 | 3 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-05 | 197 | 12 | 3 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-05 | 197 | 12 | 3 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-05 | 197 | 12 | 3 | 8c728cd3c0382c4f3e4b78647b6e1447bb40ace1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-05 | 197 | 12 | 3 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-05 | 198 | 12 | 3 | b258f672529fb2c03e62e2696d335043c4963280 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-05 | 198 | 12 | 3 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.79e-05 | 198 | 12 | 3 | a3d4b6e4259ded2193d94d2ff6d48cf67214fc35 | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 1.82e-05 | 199 | 12 | 3 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 1.82e-05 | 199 | 12 | 3 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-05 | 199 | 12 | 3 | d2f6d04045e11d81c979949d0f5c2f7380f33400 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-05 | 199 | 12 | 3 | a272c54baf8de59c0f259e6498d144a0de8d8924 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.82e-05 | 199 | 12 | 3 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.85e-05 | 200 | 12 | 3 | 1fa29a9f42987549a75dffeb177099458f7cca88 | |
| ToppCell | Biopsy_IPF-Epithelial-KRT5-/KRT17+|Biopsy_IPF / Sample group, Lineage and Cell type | 1.85e-05 | 200 | 12 | 3 | 2fc7a3b3aea711ad3d96fd9513f4b40533056d86 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.85e-05 | 200 | 12 | 3 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-05 | 200 | 12 | 3 | d87ca8b0007b1743ae23ebd3c7e8aa7f53e39335 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.85e-05 | 200 | 12 | 3 | 7595eb2a8af3de879ecaa71f3d96f890e13b59ce | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.26e-04 | 63 | 12 | 2 | 83e1c91f830aadaf13e13254ce30189fd434bcc9 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendroyte.Trf.Il33_(Il33)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.26e-04 | 63 | 12 | 2 | f2532b1aa117eea550f0ae0b599780c4fe621407 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.26e-04 | 63 | 12 | 2 | 0643435edf3280daf38c950e5bec287a9d5cb517 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendroyte.Trf.Il33_(Il33)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.26e-04 | 63 | 12 | 2 | 71c3afda6534401320791b714e3e2fe83094c914 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.20e-04 | 115 | 12 | 2 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.20e-04 | 115 | 12 | 2 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.20e-04 | 115 | 12 | 2 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Itih5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.28e-04 | 116 | 12 | 2 | 605bd4fdf547cc41783e99cd78425760ef6461ef | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.42e-04 | 118 | 12 | 2 | aefad0b35aff980b6a2a98057735442e8a65ab04 | |
| ToppCell | LPS-IL1RA-Unknown|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.42e-04 | 118 | 12 | 2 | 6cb4063b83f867b782080ce5b1199b51bb277f2a | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.96e-04 | 125 | 12 | 2 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.04e-04 | 126 | 12 | 2 | 61e599678680e5aa86291c2b347b2995014591ea | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.12e-04 | 127 | 12 | 2 | f808c727c0817ed10e76eaffa9493a516e9a6b50 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.45e-04 | 131 | 12 | 2 | 9ca209a8652aae603c4a867ea06b06ac51e7d189 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.61e-04 | 133 | 12 | 2 | 840e8240db29cd21ed9830843c0fa6d65b8f300a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.70e-04 | 134 | 12 | 2 | d63fff23040eada31bc35ba1e05b7c6a663e0037 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.70e-04 | 134 | 12 | 2 | bffd6ce8998368d4f486b64c220eab3a44ba147b | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.13e-04 | 139 | 12 | 2 | 2fdc8f36510aff24abbc79ef2a842db75a85f946 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.13e-04 | 139 | 12 | 2 | 5970a654c64e3b54f9d18c102f5b125eec892fc5 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sncg|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.39e-04 | 142 | 12 | 2 | ed91d2ef4c346f7e1a5402846e2a34cee19c24d1 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.48e-04 | 143 | 12 | 2 | ce045ec7c311a1797ae562bec114f9e90604d063 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-04 | 148 | 12 | 2 | ba277c898678dd36f8dc1d681301c71901b89055 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-04 | 148 | 12 | 2 | b4632029ebd14969bda59a1bd1454eadb8efe563 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-04 | 151 | 12 | 2 | 523dcd243c285a6b74830a93c82cca8784edd658 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-04 | 151 | 12 | 2 | f3406094ce79cc80398b82d58ca6fd87a96e68d4 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.32e-04 | 152 | 12 | 2 | fc9472bc19f997103da535b035105f01429cb08e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-04 | 154 | 12 | 2 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.51e-04 | 154 | 12 | 2 | c6ecc46b99a783373729f7fae0b23216148ffb78 | |
| ToppCell | Dendritic_Cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 7.51e-04 | 154 | 12 | 2 | 65013f696da623d37f1e3447a294dfb3c31ae93b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_DISP2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.71e-04 | 156 | 12 | 2 | 74bd8b52edce4d425bf52fce7635b23d834a017e | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.80e-04 | 157 | 12 | 2 | fc127e7720649e746f3d3f5c2e9e63784767106a | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.80e-04 | 157 | 12 | 2 | c779a53b2c67d566f5d417e753cd17196a6bfd1c | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.80e-04 | 157 | 12 | 2 | 66a191cef4aa00811bb04462310d012610006f85 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.90e-04 | 158 | 12 | 2 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.00e-04 | 159 | 12 | 2 | 24f87c666eff10c1844c900ffd7ad49fa9f80481 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.00e-04 | 159 | 12 | 2 | 7a5c94c87b73f928d4daee507f32cbe7d90e4478 | |
| ToppCell | CV-Mild-4|Mild / Virus stimulation, Condition and Cluster | 8.10e-04 | 160 | 12 | 2 | 2e24f8de5086b086863d3bf4d9afbd9bc93f4d5e | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 8.10e-04 | 160 | 12 | 2 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.10e-04 | 160 | 12 | 2 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | Control-Mast_cells-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 8.20e-04 | 161 | 12 | 2 | 5807ee48f871a3eb24ebf78fd107cf5f2a4ec846 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 8.20e-04 | 161 | 12 | 2 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.20e-04 | 161 | 12 | 2 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.20e-04 | 161 | 12 | 2 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.20e-04 | 161 | 12 | 2 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | VE-mono3|VE / Condition, Cell_class and T cell subcluster | 8.20e-04 | 161 | 12 | 2 | 7df3fefc55ab43b897fc78d1f0c7383b10ac33d5 | |
| ToppCell | VE-mono3-|VE / Condition, Cell_class and T cell subcluster | 8.20e-04 | 161 | 12 | 2 | 4e45bf7eceb0ee30dec4d8852778366776ea5a8f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.31e-04 | 162 | 12 | 2 | 3f264263878af630921911c2b344ac56eb1e7099 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.31e-04 | 162 | 12 | 2 | c5eee02836efde2108534679850c28d2b2cfce3f | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.31e-04 | 162 | 12 | 2 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.31e-04 | 162 | 12 | 2 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 8.31e-04 | 162 | 12 | 2 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 8.41e-04 | 163 | 12 | 2 | 299ac2463b7f58eee419d822a2a2d64b973d87e9 | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.51e-04 | 164 | 12 | 2 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.51e-04 | 164 | 12 | 2 | a764b79a127c8f360af0b79a1da64658badf0dfa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-04 | 164 | 12 | 2 | 01a7c335897128d3478b8b9b44fb461cab493084 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.61e-04 | 165 | 12 | 2 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| Drug | R(+)-verapamil hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 2.50e-06 | 196 | 12 | 4 | 164_UP | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.65e-06 | 199 | 12 | 4 | 4774_UP | |
| Drug | 6-hydroxynicotinic acid | 7.12e-06 | 8 | 12 | 2 | CID000072924 | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 1.21e-04 | 191 | 12 | 3 | 3291_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HG-U133A | 1.31e-04 | 196 | 12 | 3 | 490_UP | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.31e-04 | 196 | 12 | 3 | 4591_UP | |
| Drug | Lovastatin [75330-75-5]; Up 200; 9.8uM; HL60; HT_HG-U133A | 1.31e-04 | 196 | 12 | 3 | 2494_UP | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; HL60; HT_HG-U133A | 1.33e-04 | 197 | 12 | 3 | 3069_UP | |
| Drug | Sulfameter [651-06-9]; Up 200; 14.2uM; HL60; HT_HG-U133A | 1.33e-04 | 197 | 12 | 3 | 2712_UP | |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A | 1.33e-04 | 197 | 12 | 3 | 3798_DN | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.35e-04 | 198 | 12 | 3 | 4609_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A | 1.35e-04 | 198 | 12 | 3 | 5214_UP | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; HL60; HT_HG-U133A | 1.35e-04 | 198 | 12 | 3 | 6145_UP | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.39e-04 | 200 | 12 | 3 | 2919_UP | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; PC3; HT_HG-U133A | 1.39e-04 | 200 | 12 | 3 | 4481_UP | |
| Drug | Desoxycorticosterone | 2.72e-04 | 47 | 12 | 2 | ctd:D003900 | |
| Drug | Thomsen-Friedenreich antigen | 5.20e-04 | 65 | 12 | 2 | CID000065121 | |
| Drug | p,p'-DDT | 7.48e-04 | 78 | 12 | 2 | CID000003036 | |
| Drug | fluoranthene | 7.54e-04 | 851 | 12 | 4 | ctd:C007738 | |
| Drug | Raloxifene Hydrochloride | 7.75e-04 | 857 | 12 | 4 | ctd:D020849 | |
| Drug | pyrazolo(3,4-d)pyrimidine | 1.18e-03 | 98 | 12 | 2 | ctd:C014175 | |
| Drug | Chlorpyrifos | 1.18e-03 | 960 | 12 | 4 | ctd:D004390 | |
| Drug | potassium hydroxide | 1.43e-03 | 108 | 12 | 2 | CID000014797 | |
| Drug | Carmustine | 1.82e-03 | 484 | 12 | 3 | ctd:D002330 | |
| Disease | colon cancer (biomarker_via_orthology) | 1.11e-04 | 39 | 12 | 2 | DOID:219 (biomarker_via_orthology) | |
| Disease | multiple system atrophy | 1.17e-04 | 40 | 12 | 2 | EFO_1001050 | |
| Disease | Cerebrovascular accident | 2.83e-04 | 62 | 12 | 2 | C0038454 | |
| Disease | mean arterial pressure | 9.44e-04 | 499 | 12 | 3 | EFO_0006340 | |
| Disease | asthma (is_implicated_in) | 1.79e-03 | 157 | 12 | 2 | DOID:2841 (is_implicated_in) | |
| Disease | pancreatic carcinoma | 2.19e-03 | 174 | 12 | 2 | EFO_0002618 | |
| Disease | urinary albumin to creatinine ratio | 2.32e-03 | 179 | 12 | 2 | EFO_0007778 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CVSGCVCPDGLMDDG | 796 | Q02817 | |
| GGTCRGYMGGYMCEC | 1096 | Q9UM47 | |
| DKGGTCMFLGEECCY | 461 | P60507 | |
| VCCFLDGGVGLYDMG | 366 | Q8IZU2 | |
| VNGMCVCDDGYTGED | 481 | P24821 | |
| DLCEVYGGGCHGCLM | 491 | O75326 | |
| TCTCQDGYMGDGELC | 1481 | Q9NY15 | |
| LGCGEGGCGACTVML | 41 | P47989 | |
| GMDGCELMCCGRGYD | 331 | P41221 | |
| QGGVCGCEKGYTEIM | 1486 | Q9C0I4 | |
| GEEGHEGCSYTMCPE | 761 | Q63HR2 | |
| GTDGCEIMCCGRGYD | 331 | Q93097 | |
| TCECEVGYGGGLCME | 2731 | Q9Y493 |